Quick Answer
Turn Therapeutics Inc. reported Diluted EPS of $0.12 per share (loss) for fiscal year 2025.
Turn Therapeutics Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.12 | -71.4% |
| 2024 | -$0.07 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.07 | -133.3% | -133.3% |
| September 30, 2024 | -$0.03 | — | — |
- Turn Therapeutics Inc. showed a decrease of -71.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, Turn Therapeutics Inc.’s diluted eps has declined by 71.4% (from $0.07 per share (loss) to $0.12 per share (loss)).
- The most recent figure is from Turn Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: